These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 2930845)
41. Recombinant human megakaryocyte growth and development factor (rHuMGDF), a ligand for c-Mpl, produces functional human platelets in vitro. Choi ES; Hokom M; Bartley T; Li YS; Ohashi H; Kato T; Nichol JL; Skrine J; Knudten A; Chen J Stem Cells; 1995 May; 13(3):317-22. PubMed ID: 7542117 [TBL] [Abstract][Full Text] [Related]
42. Action of thrombopoietin at the megakaryocyte progenitor level is critical for the subsequent proplatelet production. Horie K; Miyazaki H; Hagiwara T; Tahara E; Matsumoto A; Kadoya T; Ogami K; Kato T Exp Hematol; 1997 Feb; 25(2):169-76. PubMed ID: 9015217 [TBL] [Abstract][Full Text] [Related]
43. [Formation of platelets from cord blood CD34+ cells-derived megakaryocytes induced by S-nitrosoglutathione]. Dai B; He J; Chen S; Liu JH; Qin F; Zhu FM; Yan LX Sheng Li Xue Bao; 2006 Oct; 58(5):490-3. PubMed ID: 17041735 [TBL] [Abstract][Full Text] [Related]
44. The humoral regulation of megakaryocytopoiesis and platelet production in vivo. Kuriya S; Murphy MJ Blood Cells; 1986; 12(1):233-47. PubMed ID: 3491644 [TBL] [Abstract][Full Text] [Related]
45. Immunology. The root of platelet production. Geddis AE; Kaushansky K Science; 2007 Sep; 317(5845):1689-91. PubMed ID: 17885117 [No Abstract] [Full Text] [Related]
46. A product of their environment: do megakaryocytes rely on extracellular cues for proplatelet formation? Larson MK; Watson SP Platelets; 2006 Nov; 17(7):435-40. PubMed ID: 17074718 [TBL] [Abstract][Full Text] [Related]
50. Methods for genetic modification of megakaryocytes and platelets. Pendaries C; Watson SP; Spalton JC Platelets; 2007 Sep; 18(6):393-408. PubMed ID: 17763148 [TBL] [Abstract][Full Text] [Related]
51. The effect of platelet homogenate fractions on megakaryocytopoiesis in the mouse. Vezendi K; Krizsa F; Szabó I; Cserháti I Haematologia (Budap); 1986; 19(2):113-6. PubMed ID: 3530905 [TBL] [Abstract][Full Text] [Related]
52. Thrombopoietic cells and the bone marrow vascular niche. Kopp HG; Rafii S Ann N Y Acad Sci; 2007 Jun; 1106():175-9. PubMed ID: 17395736 [TBL] [Abstract][Full Text] [Related]
53. [Changes in the incorporation of 35S into megakaryocytes and thrombocytes of rats at early time intervals after exposure to 8 Gy (author's transl)]. Sadílková M; Pospísil J; Dienstbier Z Sb Lek; 1981 Apr; 83(4):113-8. PubMed ID: 7256172 [No Abstract] [Full Text] [Related]
54. c-mpl, the thrombopoietin receptor. Vainchenker W; Methia N; Debili N; Titeux M; Wendling F Thromb Haemost; 1995 Jul; 74(1):526-8. PubMed ID: 8578519 [TBL] [Abstract][Full Text] [Related]
55. Is interleukin-3 a physiological regulator of megakaryocytopoiesis, in vivo? Levin J Blood Cells; 1989; 15(1):134-9. PubMed ID: 2784700 [No Abstract] [Full Text] [Related]
56. Thrombopoietin, megakaryocytopoietic cytokines, and reactive versus clonal megakaryocytopoiesis: an enigma complex. Haznedaroğlu IC; Benekli M; Dündar S Blood; 1996 Feb; 87(4):1654. PubMed ID: 8608260 [No Abstract] [Full Text] [Related]